GlaxoSmithKline PLC (NYSE:GSK)
| 33.95 Delayed Data As of Oct 28 |  -1.40 / -3.96%Today’s Change | 31.43 Today|||52-Week Range 48.25 | -27.75% Year-to-Date |
Latest GSK News | Press Releases
Today’s Trading
| Previous close | 35.35 |
| Today’s open | 34.66 |
| Day’s range | 33.87 - 34.70 |
| Volume | 2,453 |
| Average volume (3 months) | 3,265,468 |
| Market cap | $88.6B |
Data as of 4:00pm ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | +21.84% |
| Earnings growth (this year) | -7.02% |
| Earnings growth (next 5 years) | -0.15% |
| Revenue growth (last year) | +4.78% |
| P/E ratio | 9.8 |
| Price/Sales | 2.74 |
| Price/Book | 5.79 |
Competitors
Data as of 5:17pm ET, 10/28/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $43.1B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
